Neurovascular Devices Market

Global Neurovascular Devices market is set to touch US$ 5 Billion by 2025.
 
Market growth can be attributed to factors such as growing obese and ageing population, rising patient pool for hemorrhagic and ischemic stroke, ongoing product development & commercialization, increasing demand for minimally invasive procedures for the treatment of neurovascular disease, expansion of healthcare infrastructure across emerging markets and technological advancement in the field of neurovascular devices market.
 “Global Neurovascular Devices Market Analysis, Size, Share, Segmentation and Competitive Landscape (2013 – 2017) and Future Forecast (2018 – 2025)” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the global neurovascular devices market.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides in-depth analysis and information according to categories such as products, therapeutic application, geography, company and competitive landscape. A comprehensive analysis has been done on market share of all the categories. The report also includes assessment of competitive landscape analysis by companies. Key trends in terms of merger & acquisitions are analyzed with details.  The report also explores detailed description of growth drivers and inhibitors of the neurovascular devices market.
The superior geographic segments are identified in the report, which also studies the prospects showcased by the emerging markets. It covers United States, United Kingdom, France, Italy, Spain, Germany, Japan, China, India and Brazil from 2013 to 2017 and forecasts to 2025.
The report concludes with the profiles of major players in the neurovascular devices market. The major market players are evaluated on various parameters such as company overview, product portfolios, market revenue and recent development of the neurovascular devices market.
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
Stryker, Medtronic, MicroVention Terumo, Cerenovus (Johnson n Johnson), Penumbra, Microport Scientific Corporation, Integer Holdings Corporation
Market Segmentation: Global Neurovascular Devices Market
The global neurovascular devices market is classified on the basis of product type, therapeutic application, geography and company
Neurovascular Devices Market, by Products
• Coil
• Carotid Stent
• Clot Removal
• Liquid Embolic
• Coil Assist Balloon
• Coil Assist Stent
• Flow Diverter Stent
• Micro wire/Catheter
• Other Products
Neurovascular Devices Market, by Therapeutic Application
• Aneurysm
• Intracranial Atherosclerotic Disease (ICAD)
• Ischemic Stroke
• Arteriovenous Malformation (AVM)
• Other Therapeutic Applications
Neurovascular Devices Market, by Country
• United States
• France
• Germany
• Italy
• Spain
• United Kingdom
• Japan
• China
• India
• Brazil
• Rest of the World (ROW)
Neurovascular Devices Market, by Company
 
• Stryker
• Medtronic
• MicroVention Terumo
• Cerenovus (Johnson n Johnson)
• Penumbra
• Microport Scientific Corporation
• Integer Holdings Corporation
Key questions answered in this research report:
 
• At what pace is the neurovascular devices market growing, globally? What will be growth
  trend in future?
• What are the key drivers and inhibitors in the current market? What will be the impact of drivers
  and inhibitors in the future?
• What is the country revenue and forecast breakdowns? Which are the major country revenue
   pockets for growth in the neurovascular devices market?
• What are the various application areas and how they are poised to grow?
• How is the market predicted to develop in the future?
• Who are the market players?

Diabetes Insulin Delivery Pens Market Research Report 2018

Diabetes Insulin Delivery Pen market will surpass US$ 14.4 Billion by 2025.
Market growth can be attributed to factors such as growing diabetes patient population, high adoption rate, user–friendly design, rising popularity among consumers, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs, government support and technological advancements in the field of insulin pen devices.
 
“Diabetes Insulin Delivery Pens Market Research Report 2018” presents an in-depth assessment of the diabetes insulin delivery pen market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for diabetes insulin delivery pen market. The report includes historic data from 2011 to 2017 and forecasts until 2025.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, insulin pen volume, revenues for insulin pen and its segments reusable and disposable insulin pen and illustrative forecast to 2025.It also provides an all-round analysis of overall number of patients with diabetes and insulin users. A comprehensive analysis has been done on market share of diabetes insulin delivery pen segment and countries-based market. The report also explores detailed description of growth drivers and inhibitors of the diabetes insulin delivery pens market.
The superior geographic segments are identified in the report, which also studies the prospects showcased by the emerging markets. It covers United States, United Kingdom, France, Italy, Spain, Germany, Japan, China, India and Brazil from 2011 to 2017 and forecasts to 2025.
The report concludes with the profiles of major players in the diabetes insulin delivery pens market. The key market players are evaluated on various parameters such as company overview, product portfolios and recent development of the diabetes insulin delivery pens market.
Market segment by Type, the product can be split into
• Reusable Insulin Pens
• Disposable Insulin Pens
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd.
Major Countries Analyzed Under This Report are:
United States, United Kingdom, France, Italy, Spain, Germany, Japan, China, India and Brazil
The Latest Industry Data Included in this Report:
• Diabetes Population in 10 major markets(10MM) 2011-2025
• Insulin Users Insights in 10 major markets(10MM) 2011 – 2025
• Total Diabetes Insulin Delivery Pen Users (Volume),2011 – 2025
• Reusable (Cartridge) Insulin Delivery Pen Users (Volume),2011 – 2025
• Prefilled (Disposable) Insulin Delivery Pen Users (Volume),2011 – 2025
• Total Diabetes Insulin Delivery Pen Market Size & Analysis (Value)2011-2025
• Reusable (Cartridge) Insulin Delivery Pen Market (Value),2011-2025
• Prefilled (Disposable) Insulin Delivery Pen Market (Value),2011-2025
• Total Diabetes Insulin Delivery Pen Market Share, By Users (%),2011 – 2025
• Reusable (Cartridge) Insulin Delivery Pen Market Share, By Users (%)2011 – 2025
• Prefilled (Disposable) Insulin Delivery Pen Market Share, By Users (%), 2011 – 2025
• Total Diabetes Insulin Delivery Pen Market Share (%),2011 – 2025
• Reusable (Cartridge) Insulin Delivery Pen Market Share (%),2011 – 2025
• Prefilled (Disposable) Insulin Delivery Pen Market Share (%),2011 – 2025
• Diabetes Insulin Delivery Pen Market, By Geography (Volume and Value),2011 – 2025
• Market Definition for the Specified Topic Along with Identification of Key Drivers
  and Inhibitors for the Market
• A Comprehensive List of Key Market Players Along with the Analysis of their Current
  Product Portfolios and Recent Development